ZipBio utilizes generative artificial Intelligence to revolutionize the development of new therapeutics, addressing some of the most pressing unmet needs in medicine. By creating de novo genes and proteins, the company's solution distill multiple complex functions into compact, highly effective therapeutic molecules.